These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28566245)

  • 1. Validity Assessment of Low-risk SCORE Function and SCORE Function Calibrated to the Spanish Population in the FRESCO Cohorts.
    Baena-Díez JM; Subirana I; Ramos R; Gómez de la Cámara A; Elosua R; Vila J; Marín-Ibáñez A; Guembe MJ; Rigo F; Tormo-Díaz MJ; Moreno-Iribas C; Cabré JJ; Segura A; Lapetra J; Quesada M; Medrano MJ; González-Diego P; Frontera G; Gavrila D; Ardanaz E; Basora J; García JM; García-Lareo M; Gutiérrez-Fuentes JA; Mayoral E; Sala J; Dégano IR; Francès A; Castell C; Grau M; Marrugat J
    Rev Esp Cardiol (Engl Ed); 2018 Apr; 71(4):274-282. PubMed ID: 28566245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ERICE-score: the new native cardiovascular score for the low-risk and aged Mediterranean population of Spain.
    Gabriel R; Brotons C; Tormo MJ; Segura A; Rigo F; Elosua R; Carbayo JA; Gavrila D; Moral I; Tuomilehto J; Muñiz J;
    Rev Esp Cardiol (Engl Ed); 2015 Mar; 68(3):205-15. PubMed ID: 25155342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study].
    Marrugat J; Vila J; Baena-Díez JM; Grau M; Sala J; Ramos R; Subirana I; Fitó M; Elosua R
    Rev Esp Cardiol; 2011 May; 64(5):385-94. PubMed ID: 21482004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of Lifetime Risk of Cardiovascular Disease (IBERLIFERISK): A New Tool for Cardiovascular Disease Prevention in Primary Care.
    Brotons C; Moral I; Fernández D; Puig M; Calvo Bonacho E; Martínez Muñoz P; Catalina Romero C; Quevedo Aguado LJ
    Rev Esp Cardiol (Engl Ed); 2019 Jul; 72(7):562-568. PubMed ID: 30097396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calibrating the SCORE cardiovascular risk chart for use in Spain].
    Sans S; Fitzgerald AP; Royo D; Conroy R; Graham I
    Rev Esp Cardiol; 2007 May; 60(5):476-85. PubMed ID: 17535758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: the FRESCO Study.
    Marrugat J; Subirana I; Ramos R; Vila J; Marín-Ibañez A; Guembe MJ; Rigo F; Tormo Díaz MJ; Moreno-Iribas C; Cabré JJ; Segura A; Baena-Díez JM; de la Cámara AG; Lapetra J; Grau M; Quesada M; Medrano MJ; González Diego P; Frontera G; Gavrila D; Aicua EA; Basora J; García JM; García-Lareo M; Gutierrez JA; Mayoral E; Sala J; D'Agostino R; Elosua R;
    Prev Med; 2014 Apr; 61():66-74. PubMed ID: 24412897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of using different SCORE tables for estimating cardiovascular risk.
    Brotons C; Moral I; Soriano N; Cuixart L; Osorio D; Bottaro D; Puig M; Joaniquet X; Marcos A; Casasa A
    Rev Esp Cardiol (Engl Ed); 2014 Feb; 67(2):94-100. PubMed ID: 24795115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Validation of the SCORE index and SCORE for old people in the Castilla y Léon cardiovascular disease risk cohort].
    Vega Alonso AT; Ordax Díez A; Lozano Alonso JE; Álamo Sanz R; Lleras Muñoz S; García Palomar P;
    Hipertens Riesgo Vasc; 2019; 36(4):184-192. PubMed ID: 30926254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk estimation in older persons: SCORE O.P.
    Cooney MT; Selmer R; Lindman A; Tverdal A; Menotti A; Thomsen T; DeBacker G; De Bacquer D; Tell GS; Njolstad I; Graham IM;
    Eur J Prev Cardiol; 2016 Jul; 23(10):1093-103. PubMed ID: 26040999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study.
    Goh LG; Welborn TA; Dhaliwal SS
    BMC Womens Health; 2014 Sep; 14():118. PubMed ID: 25255986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland.
    Marques-Vidal P; Rodondi N; Bochud M; Pécoud A; Hayoz D; Paccaud F; Mooser V; Waeber G; Vollenweider P
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):402-8. PubMed ID: 18677163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.
    Herrera S; Guelar A; Sorlì L; Vila J; Molas E; Grau M; Marrugat J; Esteve E; Güerri-Fernández R; Montero M; Knobel H
    HIV Clin Trials; 2016 Jul; 17(4):131-9. PubMed ID: 27169692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Framingham function estimates the risk of cardio vascular mortality more effectively than SCORE function in the population of the Canary Islands (Spain)].
    Cabrera de León A; Alemán Sánchez JJ; Rodríguez Pérez MC; del Castillo-Rodríguez JC; Domínguez-Coello S; Almeida-González D; Anía Lafuente B; Aguirre Jaime A; Brito Díaz B
    Gac Sanit; 2009; 23(3):216-21. PubMed ID: 19250709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe.
    Artigao-Rodenas LM; Carbayo-Herencia JA; Divisón-Garrote JA; Gil-Guillén VF; Massó-Orozco J; Simarro-Rueda M; Molina-Escribano F; Sanchis C; Carrión-Valero L; López de Coca E; Caldevilla D; López-Abril J; Carratalá-Munuera C; Lopez-Pineda A;
    PLoS One; 2013; 8(9):e73529. PubMed ID: 24039972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calibration between the Estimated Probability of the Risk Assessment Chart of Japan Atherosclerosis Society and Actual Mortality Using External Population: Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN).
    Nakai M; Miyamoto Y; Higashiyama A; Murakami Y; Nishimura K; Yatsuya H; Saitoh S; Sakata K; Iso H; Miura K; Ueshima H; Okamura T;
    J Atheroscler Thromb; 2016; 23(2):176-95. PubMed ID: 26347049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study.
    Mortensen MB; Afzal S; Nordestgaard BG; Falk E
    Eur Heart J; 2015 Sep; 36(36):2446-53. PubMed ID: 26082084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating Cardiovascular Risk in Spain by the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice.
    Amor AJ; Masana L; Soriguer F; Goday A; Calle-Pascual A; Gaztambide S; Rojo-Martínez G; Valdés S; Gomis R; Ortega E;
    Rev Esp Cardiol (Engl Ed); 2015 May; 68(5):417-25. PubMed ID: 25444376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of a long-term cardiovascular disease risk prediction equation for low-incidence populations: the CAMUNI-MATISS Cohorts Collaboration study.
    Veronesi G; Gianfagna F; Giampaoli S; Chambless LE; Grassi G; Cesana G; Ferrario MM
    Eur J Prev Cardiol; 2015 Dec; 22(12):1618-25. PubMed ID: 25501263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
    Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.